Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 7 |
NetGPI | no | yes: 0, no: 7 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005789 | endoplasmic reticulum membrane | 4 | 8 |
GO:0016020 | membrane | 2 | 8 |
GO:0031090 | organelle membrane | 3 | 8 |
GO:0031966 | mitochondrial membrane | 4 | 8 |
GO:0110165 | cellular anatomical entity | 1 | 8 |
Related structures:
AlphaFold database: Q4Q632
Term | Name | Level | Count |
---|---|---|---|
GO:0006629 | lipid metabolic process | 3 | 8 |
GO:0006644 | phospholipid metabolic process | 4 | 8 |
GO:0006650 | glycerophospholipid metabolic process | 5 | 8 |
GO:0006656 | phosphatidylcholine biosynthetic process | 5 | 8 |
GO:0006793 | phosphorus metabolic process | 3 | 8 |
GO:0006796 | phosphate-containing compound metabolic process | 4 | 8 |
GO:0006807 | nitrogen compound metabolic process | 2 | 8 |
GO:0008152 | metabolic process | 1 | 8 |
GO:0008610 | lipid biosynthetic process | 4 | 8 |
GO:0008654 | phospholipid biosynthetic process | 5 | 8 |
GO:0009058 | biosynthetic process | 2 | 8 |
GO:0009987 | cellular process | 1 | 8 |
GO:0019637 | organophosphate metabolic process | 3 | 8 |
GO:0032259 | methylation | 2 | 8 |
GO:0044237 | cellular metabolic process | 2 | 8 |
GO:0044238 | primary metabolic process | 2 | 8 |
GO:0044249 | cellular biosynthetic process | 3 | 8 |
GO:0044255 | cellular lipid metabolic process | 3 | 8 |
GO:0045017 | glycerolipid biosynthetic process | 4 | 8 |
GO:0046470 | phosphatidylcholine metabolic process | 4 | 8 |
GO:0046474 | glycerophospholipid biosynthetic process | 5 | 8 |
GO:0046486 | glycerolipid metabolic process | 4 | 8 |
GO:0071704 | organic substance metabolic process | 2 | 8 |
GO:0090407 | organophosphate biosynthetic process | 4 | 8 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 8 |
GO:1901566 | organonitrogen compound biosynthetic process | 4 | 8 |
GO:1901576 | organic substance biosynthetic process | 3 | 8 |
Term | Name | Level | Count |
---|---|---|---|
GO:0000773 | phosphatidyl-N-methylethanolamine N-methyltransferase activity | 6 | 8 |
GO:0003824 | catalytic activity | 1 | 8 |
GO:0004608 | phosphatidylethanolamine N-methyltransferase activity | 6 | 8 |
GO:0008168 | methyltransferase activity | 4 | 8 |
GO:0008170 | N-methyltransferase activity | 5 | 8 |
GO:0008757 | S-adenosylmethionine-dependent methyltransferase activity | 5 | 8 |
GO:0016740 | transferase activity | 2 | 8 |
GO:0016741 | transferase activity, transferring one-carbon groups | 3 | 8 |
GO:0080101 | phosphatidyl-N-dimethylethanolamine N-methyltransferase activity | 6 | 8 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 206 | 208 | PF00675 | 0.377 |
CLV_NRD_NRD_1 | 41 | 43 | PF00675 | 0.368 |
CLV_PCSK_KEX2_1 | 208 | 210 | PF00082 | 0.328 |
CLV_PCSK_KEX2_1 | 41 | 43 | PF00082 | 0.404 |
CLV_PCSK_PC1ET2_1 | 208 | 210 | PF00082 | 0.328 |
CLV_PCSK_PC7_1 | 37 | 43 | PF00082 | 0.385 |
DEG_SCF_FBW7_1 | 4 | 11 | PF00400 | 0.376 |
DOC_CKS1_1 | 5 | 10 | PF01111 | 0.407 |
DOC_PP4_FxxP_1 | 155 | 158 | PF00568 | 0.489 |
DOC_PP4_FxxP_1 | 197 | 200 | PF00568 | 0.528 |
DOC_USP7_MATH_1 | 216 | 220 | PF00917 | 0.630 |
DOC_USP7_MATH_1 | 8 | 12 | PF00917 | 0.444 |
DOC_WW_Pin1_4 | 196 | 201 | PF00397 | 0.493 |
DOC_WW_Pin1_4 | 4 | 9 | PF00397 | 0.411 |
LIG_14-3-3_CanoR_1 | 146 | 152 | PF00244 | 0.489 |
LIG_BRCT_BRCA1_1 | 82 | 86 | PF00533 | 0.388 |
LIG_FHA_1 | 116 | 122 | PF00498 | 0.474 |
LIG_FHA_1 | 181 | 187 | PF00498 | 0.402 |
LIG_FHA_1 | 200 | 206 | PF00498 | 0.481 |
LIG_FHA_1 | 89 | 95 | PF00498 | 0.460 |
LIG_LIR_Apic_2 | 153 | 158 | PF02991 | 0.489 |
LIG_LIR_Apic_2 | 194 | 200 | PF02991 | 0.310 |
LIG_LIR_Gen_1 | 123 | 130 | PF02991 | 0.389 |
LIG_LIR_Gen_1 | 30 | 40 | PF02991 | 0.440 |
LIG_LIR_LC3C_4 | 118 | 122 | PF02991 | 0.435 |
LIG_LIR_Nem_3 | 123 | 128 | PF02991 | 0.340 |
LIG_LIR_Nem_3 | 137 | 142 | PF02991 | 0.406 |
LIG_LIR_Nem_3 | 30 | 35 | PF02991 | 0.377 |
LIG_LIR_Nem_3 | 83 | 89 | PF02991 | 0.469 |
LIG_Pex14_2 | 197 | 201 | PF04695 | 0.512 |
LIG_PTB_Apo_2 | 154 | 161 | PF02174 | 0.528 |
LIG_PTB_Phospho_1 | 154 | 160 | PF10480 | 0.528 |
LIG_SH2_CRK | 15 | 19 | PF00017 | 0.348 |
LIG_SH2_STAT5 | 134 | 137 | PF00017 | 0.489 |
LIG_SH2_STAT5 | 138 | 141 | PF00017 | 0.489 |
LIG_SH2_STAT5 | 160 | 163 | PF00017 | 0.348 |
LIG_SH2_STAT5 | 196 | 199 | PF00017 | 0.504 |
LIG_SH2_STAT5 | 57 | 60 | PF00017 | 0.351 |
LIG_SH3_3 | 2 | 8 | PF00018 | 0.418 |
LIG_SUMO_SIM_par_1 | 118 | 124 | PF11976 | 0.473 |
LIG_TYR_ITIM | 13 | 18 | PF00017 | 0.282 |
LIG_WRC_WIRS_1 | 122 | 127 | PF05994 | 0.473 |
MOD_CK1_1 | 199 | 205 | PF00069 | 0.468 |
MOD_Cter_Amidation | 50 | 53 | PF01082 | 0.378 |
MOD_GlcNHglycan | 218 | 221 | PF01048 | 0.438 |
MOD_GlcNHglycan | 66 | 69 | PF01048 | 0.450 |
MOD_GSK3_1 | 116 | 123 | PF00069 | 0.348 |
MOD_GSK3_1 | 4 | 11 | PF00069 | 0.425 |
MOD_NEK2_1 | 120 | 125 | PF00069 | 0.305 |
MOD_NEK2_1 | 128 | 133 | PF00069 | 0.302 |
MOD_NEK2_1 | 168 | 173 | PF00069 | 0.383 |
MOD_NEK2_1 | 64 | 69 | PF00069 | 0.310 |
MOD_PIKK_1 | 88 | 94 | PF00454 | 0.425 |
MOD_PKA_1 | 41 | 47 | PF00069 | 0.558 |
MOD_PKA_2 | 145 | 151 | PF00069 | 0.489 |
MOD_PKA_2 | 41 | 47 | PF00069 | 0.597 |
MOD_Plk_4 | 116 | 122 | PF00069 | 0.348 |
MOD_Plk_4 | 130 | 136 | PF00069 | 0.348 |
MOD_Plk_4 | 177 | 183 | PF00069 | 0.438 |
MOD_Plk_4 | 27 | 33 | PF00069 | 0.402 |
MOD_Plk_4 | 81 | 87 | PF00069 | 0.394 |
MOD_ProDKin_1 | 196 | 202 | PF00069 | 0.493 |
MOD_ProDKin_1 | 4 | 10 | PF00069 | 0.409 |
TRG_AP2beta_CARGO_1 | 137 | 146 | PF09066 | 0.489 |
TRG_ENDOCYTIC_2 | 138 | 141 | PF00928 | 0.499 |
TRG_ENDOCYTIC_2 | 15 | 18 | PF00928 | 0.348 |
TRG_ER_diArg_1 | 206 | 209 | PF00400 | 0.582 |
TRG_ER_diArg_1 | 40 | 42 | PF00400 | 0.600 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P6H5 | Leptomonas seymouri | 67% | 100% |
A0A0S4IUX3 | Bodo saltans | 53% | 100% |
A0A3Q8IF09 | Leishmania donovani | 90% | 100% |
A4HJL2 | Leishmania braziliensis | 80% | 97% |
A4I735 | Leishmania infantum | 89% | 100% |
C8VRV0 | Emericella nidulans (strain FGSC A4 / ATCC 38163 / CBS 112.46 / NRRL 194 / M139) | 43% | 100% |
E9B230 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 90% | 100% |
O74827 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 44% | 100% |
P05375 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) | 44% | 100% |
Q08388 | Rattus norvegicus | 40% | 100% |
Q54H80 | Dictyostelium discoideum | 28% | 100% |
Q54SD5 | Dictyostelium discoideum | 39% | 100% |
Q61907 | Mus musculus | 39% | 100% |
Q7S5W9 | Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) | 46% | 100% |
Q7YRH6 | Bos taurus | 42% | 100% |
Q9UBM1 | Homo sapiens | 41% | 100% |